Cargando…

Hydrophilic High Drug-Loaded 3D Printed Gastroretentive System with Robust Release Kinetics

Three-dimensional printing (3DP) technology enables an important improvement in the design of new drug delivery systems, such as gastroretentive floating tablets. These systems show a better temporal and spatial control of the drug release and can be customized based on individual therapeutic needs....

Descripción completa

Detalles Bibliográficos
Autores principales: Mora-Castaño, Gloria, Millán-Jiménez, Mónica, Caraballo, Isidoro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057139/
https://www.ncbi.nlm.nih.gov/pubmed/36986703
http://dx.doi.org/10.3390/pharmaceutics15030842
_version_ 1785016288933838848
author Mora-Castaño, Gloria
Millán-Jiménez, Mónica
Caraballo, Isidoro
author_facet Mora-Castaño, Gloria
Millán-Jiménez, Mónica
Caraballo, Isidoro
author_sort Mora-Castaño, Gloria
collection PubMed
description Three-dimensional printing (3DP) technology enables an important improvement in the design of new drug delivery systems, such as gastroretentive floating tablets. These systems show a better temporal and spatial control of the drug release and can be customized based on individual therapeutic needs. The aim of this work was to prepare 3DP gastroretentive floating tablets designed to provide a controlled release of the API. Metformin was used as a non-molten model drug and hydroxypropylmethyl cellulose with null or negligible toxicity was the main carrier. High drug loads were assayed. Another objective was to maintain the release kinetics as robust as possible when varying drug doses from one patient to another. Floating tablets using 10–50% w/w drug-loaded filaments were obtained by Fused Deposition Modelling (FDM) 3DP. The sealing layers of our design allowed successful buoyancy of the systems and sustained drug release for more than 8 h. Moreover, the effect of different variables on the drug release behaviour was studied. It should be highlighted that the robustness of the release kinetics was affected by varying the internal mesh size, and therefore the drug load. This could represent a step forward in the personalization of the treatments, a key advantage of 3DP technology in the pharmaceutical field.
format Online
Article
Text
id pubmed-10057139
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100571392023-03-30 Hydrophilic High Drug-Loaded 3D Printed Gastroretentive System with Robust Release Kinetics Mora-Castaño, Gloria Millán-Jiménez, Mónica Caraballo, Isidoro Pharmaceutics Article Three-dimensional printing (3DP) technology enables an important improvement in the design of new drug delivery systems, such as gastroretentive floating tablets. These systems show a better temporal and spatial control of the drug release and can be customized based on individual therapeutic needs. The aim of this work was to prepare 3DP gastroretentive floating tablets designed to provide a controlled release of the API. Metformin was used as a non-molten model drug and hydroxypropylmethyl cellulose with null or negligible toxicity was the main carrier. High drug loads were assayed. Another objective was to maintain the release kinetics as robust as possible when varying drug doses from one patient to another. Floating tablets using 10–50% w/w drug-loaded filaments were obtained by Fused Deposition Modelling (FDM) 3DP. The sealing layers of our design allowed successful buoyancy of the systems and sustained drug release for more than 8 h. Moreover, the effect of different variables on the drug release behaviour was studied. It should be highlighted that the robustness of the release kinetics was affected by varying the internal mesh size, and therefore the drug load. This could represent a step forward in the personalization of the treatments, a key advantage of 3DP technology in the pharmaceutical field. MDPI 2023-03-04 /pmc/articles/PMC10057139/ /pubmed/36986703 http://dx.doi.org/10.3390/pharmaceutics15030842 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mora-Castaño, Gloria
Millán-Jiménez, Mónica
Caraballo, Isidoro
Hydrophilic High Drug-Loaded 3D Printed Gastroretentive System with Robust Release Kinetics
title Hydrophilic High Drug-Loaded 3D Printed Gastroretentive System with Robust Release Kinetics
title_full Hydrophilic High Drug-Loaded 3D Printed Gastroretentive System with Robust Release Kinetics
title_fullStr Hydrophilic High Drug-Loaded 3D Printed Gastroretentive System with Robust Release Kinetics
title_full_unstemmed Hydrophilic High Drug-Loaded 3D Printed Gastroretentive System with Robust Release Kinetics
title_short Hydrophilic High Drug-Loaded 3D Printed Gastroretentive System with Robust Release Kinetics
title_sort hydrophilic high drug-loaded 3d printed gastroretentive system with robust release kinetics
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057139/
https://www.ncbi.nlm.nih.gov/pubmed/36986703
http://dx.doi.org/10.3390/pharmaceutics15030842
work_keys_str_mv AT moracastanogloria hydrophilichighdrugloaded3dprintedgastroretentivesystemwithrobustreleasekinetics
AT millanjimenezmonica hydrophilichighdrugloaded3dprintedgastroretentivesystemwithrobustreleasekinetics
AT caraballoisidoro hydrophilichighdrugloaded3dprintedgastroretentivesystemwithrobustreleasekinetics